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Recently, a new paramyxovirus, now known as Nipah virus (NV), emerged in Malaysia and Singapore, causing fatal
encephalitis in humans and a respiratory syndrome in pigs. Initial studies had indicated that NV is antigenically and
genetically related to Hendra virus (HV). We generated the sequences of the N, P/C/V, M, F, and G genes of NV and compared
these sequences with those of HV and other members of the family Paramyxoviridae. The intergenic regions of NV were
identical to those of HV, and the gene start and stop sequences of NV were nearly identical to those of HV. The open reading
frames (ORFs) for the V and C proteins within the P gene were found in NV, but the ORF encoding a potential short basic
protein found in the P gene of HV was not conserved in NV. The N, P, C, V, M, F, and G ORFs in NV have nucleotide homologies
ranging from 88% to 70% and predicted amino acid homologies ranging from 92% to 67% in comparison with HV. The
predicted fusion cleavage sequence of the F protein of NV had a single amino acid substitution (K to R) in comparison with
HV. Phylogenetic analysis demonstrated that although HV and NV are closely related, they are clearly distinct from any of the
established genera within the Paramyxoviridae and should be considered a new genus. © 2000 Academic PressINTRODUCTION
Nipah virus (NV) was isolated in March 1999 and
subsequently identified as the etiological agent respon-
sible for an outbreak of fatal viral encephalitis in Malay-
sia and Singapore. The outbreak, which began in the fall
of 1998, reached its peak in the spring of 1999; overall,
there were 265 human cases reported and 105 fatalities.
NV also caused a respiratory illness and, to a lesser
extent than in humans, a central nervous system disease
in swine. Most human cases occurred in individuals who
had occupational exposure to pigs (Anonymous, 1999a,b;
Chua et al., 1999, 2000; Paton et al., 1999). The outbreak
was controlled only after the new virus etiology was
realized, swine were identified as the source of the virus
infecting the humans, and more than 1 million swine in
the affected areas were culled (Anonymous, 1999a).
Therefore, this outbreak was devastating not only be-
cause of the loss of human life but also because of the
severe economic loss suffered by the Malaysian swine
industry. NV was isolated from both swine lung tissue
and human brain tissue, and electron microscopy indi-
cated that NV had structural features that were most
consistent with those of the family Paramyxoviridae
(anonymous, 1999a; Chua et al., 2000). NV shared anti-
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334genic cross-reactivity with only Hendra virus (HV), and
sequence obtained from NV had more homology with HV
than with any other paramyxovirus (Anonymous, 1999a;
Chua et al., 2000).
HV, formerly known as equine morbillivirus, was first
isolated during an outbreak of a severe respiratory
illness that killed 14 horses and one human in Hendra,
Queensland, Australia, in September 1994 (Murray,
1995; Selvey, 1994). The virus also caused the deaths
of two horses and a human in the community of
Mackay, 800 km north of Hendra (Rogers, 1996). Anti-
body to HV has been detected in four species of fruit
bats (flying foxes) indigenous to Australia: the gray-
headed (Pteropus poliocephalus), black (P. alecto), lit-
tle red (P. scapulatus), and spectacled (P. conspicilla-
tus) fruit bats (Mackenzie, 1999; Young et al., 1996). In
addition, a virus identical to HV has been isolated from
two gray-headed flying foxes, one black flying fox, and
a little red flying fox (Halpin, 1996). Thus the Pteropus
species are currently thought to be the natural host of
HV (Halpin, 1996; Mackenzie, 1999; Young et al., 1996).
The ultrastructural features and gene organization of
HV indicate that it is a member of the family Paramyxo-
viridae (Hyatt, 1996; Murray, 1995). However, phyloge-
netic analysis has shown that HV does not belong to
any of the known genera within the Paramyxoviridae
(Gould, 1996; Murray, 1995; Wang et al., 1998; Yu et al.,
1998a,b). Although HV is serologically cross-reactive
with NV in immunofluorescence assays (Anonymous,
1
r
(
were u
a es.
335MOLECULAR CHARACTERIZATION OF NIPAH VIRUS1999a), it is not serologically cross-reactive with other
members of the Paramyxoviridae (Murray, 1995).
The family Paramyxoviridae contains two subfamilies:
the Paramyxovirinae and the Pneumovirinae. The sub-
family Paramyxovirinae contains three genera: rubulavi-
ruses, respiroviruses, and morbilliviruses (Bellini et al.,
998; Pringle, 1998), and HV has been proposed to be a
epresentative of a fourth genus within this subfamily
Wang et al., 1998; Yu et al., 1998b). In this study, we
compared the nucleocapsid (N), phosphoprotein (P), ma-
trix (M), fusion (F), and glycoprotein (G) genes of NV to
HV and to other members of the subfamily Paramyxoviri-
nae. We found that HV and NV form a group distinct from
any of the other established genera within the Paramyxo-
virinae and, therefore, should be considered as mem-
bers of a new genus.
RESULTS
Cloning and sequencing strategies
Primers specific for the N, P, and M genes of HV were
used to amplify parts of the N, P, and M genes of NV (Fig.
1, amplimers E, A, and H, respectively). These three
amplimers were then used as starting points to “walk up
and down” the genome by using additional reverse tran-
scription–polymerase chain reaction (RT–PCR) primers
that were derived from HV sequences in regions of
homology shared between most paramyxoviruses (Fig. 1,
amplimers G, C, J, K, and M). 59 Rapid amplification of
cDNA ends (RACE) was used to clone a section of the P
gene that has low homology to HV and other paramyxo-
viruses (Fig. 1, fragment D). A primer consisting of 35
deoxythymidines and a gene-specific primer were used
to amplify the 39 ends of the genes (Fig. 1, amplimers F,
B, I, and N).
The strategy described above failed when we at-
tempted to obtain the NV F and G gene sequences. To
FIG. 1. PCR products used to obtain the sequence of the N, P, M, F,
location and size of the amplimers used to derive the sequence of the
genome, the shaded regions represent the predicted ORFs for the N, P
and the thick vertical bars represent the intergenic regions. Amplimer
was generated using the 59 RACE method. Amplimers G, J, K, L, and M
mplimers containing the complete ORFs of the N, P, M, F, and G genobtain the open reading frames (ORFs) of the F and G
genes of NV, a cDNA library was constructed usingmRNA derived from NV-infected Vero E6 cells. The cDNA
library was screened using a probe consisting of either
the F ORF or the G ORF from HV. Plasmid clones that
contained the entire F or G ORFs were identified and
sequenced.
Once a complete ORF was assembled, RT–PCR prim-
ers were constructed to amplify the entire ORF from RNA
for additional sequencing (Fig. 1, amplimers O, P, Q, R,
and S). All coding regions were sequenced a minimum of
10 times, and the nontranslated and intergenic regions
were sequenced a minimum of 6 times. The complete
nucleotide sequence of all of the genes reported here
have been deposited in GenBank (accession numbers
AF212302 for the N, P, and M; AF238466 for F; and
AF238467 for G). We also sequenced the N, P, M, F, and
G ORFs of HV and found 3 nucleotide (nt) differences in
P, 2 nt differences in the M, 3 nt differences in F, and 4
differences in G between our sequence and the previ-
ously published sequence for HV (GenBank accession
number AF017149).
Intergenic regions and transcriptional start and stop
signals
The N, P, M, F, and G genes of NV are flanked by the
intergenic sequence, GAA, which is identical to that
found in HV, the morbilliviruses, and the respiroviruses
(Table 1). The predicted transcriptional initiation signal
for the N, P, M, and F genes of NV are identical to
those in HV, whereas there is a single nucleotide
change in the gene start of the G gene. The gene start
signals of HV and NV are more closely related to those
of the morbilliviruses and the respiroviruses than to
those of the rubulaviruses (Table 1). Except for the M
and F genes, which have 2 nt changes in each, the
transcriptional termination signals of NV are identical
to those of HV (Table 1). The termination signal for the
N gene of NV differs by only 1 nt from those of the
genes of NV. Schematic representation of the genome of NV and the
including the nontranslated and intergenic regions. On the schematic
and G genes, the open (white) areas represent nontranslated regions,
and H were used as starting points for genome walking. Fragment D
sed to identify the intergenic regions. Amplimers O, P, Q, R, and S areand G
genes,
, M, F,
s E, A,respiroviruses, Sendai virus, and human parainfluenza
virus 3 (HPIV-3), and the termination signal for the P
or HN
re AF0
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T
Comparison of the Intergenic Sequences and
and Other Members of t
Genes Virus Gen
1-N
HV
NV
MV
CDV
Sendai
HPIV-3
Mumps
N-P
HV A
NV A
MV A
CDV A
Sendai C
HPIV-3 C
Mumps UCAGAAA
P-M
HV A
NV A
MV A
CDV A
Sendai A
HPIV-3 A
Mumps GGAUAAU
M-F
HV A
NV A
MV
CDV A
Sendai U
HPIV-3 U
Mumps CUUUAAU
F-G (H, HN, SH)
HV AA
NV AA
MV
CDV UA
Sendai U
HPIV-3 C
Mumps UUUCUAAA
G (H, HN)
HV UA
NV UA
MV
CDV AA
Sendai A
HPIV-3 UA
Mumps CUAAUAA
Note. Genomic sequences are shown. Abbreviations: 1-N, 39 leader s
P-M, phosphoprotein gene to the matrix gene; M-F, matrix gene to the
HV, the hemagglutinin (H) gene of MV and CDV, the hemagglutinin-ne
gene of mumps virus; and the G (H, HN) transcriptional stop for the G, H
Bellini et al. (1998). The accession numbers for HV, CDV, and HPIV-3 aviruses (Table 1). Thus the NV termination signals of N,
P, and M are more closely related to the respirovirusesthan to the morbilliviruses. However, the gene termi-
riptional Start and Stop Signals of NV and HV
family Paramyxovirinae
Junction Gene start
GAA UCCUUGGUUCU
GAA UCCUUGGUUCU
GAA UCCUAAGUUCU
GAA UCCCAGUUACU
GAA UCCCAGUUUC
GAA UCCUAAUUUC
UUCGGUCCUUCACC
UUUU GAA UCCUAGGUUCU
UUUU GAA UCCUAGGUUCU
UUUU GAA UCCUUGGUCCA
UUUU GAA UCCUGGGUCCA
UUUU GAA UCCCACUUUC
UUUU GAA UCCUAAUUGC
UUUU AA UCCGGGCCUUUCUU
UUUU GAA UCCUCUGUCCA
UUUU GAA UCCUCUGUCCA
UUUU GAA UCCUCGUUUCA
UUUU GAA UCCUGUUCUCG
UUUU GAA UCCCACUUUC
UUUU GAA UCCUAUUUUC
UUUU A UUCGUGCUUGUGUU
UUUU GAA UCCUCGGUUC
UUUU GAA UCCUCGGUUC
UUUU GAA UCCCGGUUCC
UUUU GAA UCCCAGGUCC
UUUU GAA UCCCUAUUUC
UUUU GAA UCCUAGUUUC
UUUU A UUCGGAUCUUCCUA
UUUU GAA UCCUGGGUUCA
UUUU GAA UCCUGGGUCCA
UUUU GAA UCCCACGUUCU
UUUU GAA UCCCGAGUCCA
UUUU GAA UCCCACUUUCA
UUUU GAA UCCUUGUUUCA
UUUU GAUUUA UUCUUACUUAGAGG
UUUU
UUUU
UUUU
UUUU
UUUU
UUUU
UUUU
ce to the N gene; N-P, nucleocapsid gene to the phosphoprotein gene;
gene; F-G (H, HN, SH) fusion gene to the glycoprotein (G) of NV and
idase (HN) gene of Sendai and HPIV-3, or the short-hydrophobic (SH)
gene. The sequences for MV, Sendai, and mumps were obtained from
17149, AF014953, and D84095, respectively.ABLE 1
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e stop
AUUCU
AUUCU
AUAUU
AUAUU
AUUCU
AUUCU
UUCUU
AUUCU
AUUCU
AUAUU
AUAUU
AUUCU
AUUCU
UUAUU
AUUCU
AUGUU
UUUG
AUUAG
AUUCU
UUAGU
AUCUU
AUGUU
UUAUU
UUAA
AUUUC
AUUCU
AUGUU
UCUUU
AUUCU
AUUCU
AUUCU
UAUUU
AUUCU
AUGUU
UUCUU
equen
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uraminnation signals of the F and G genes and the gene start
signals of HV and NV for all of the genes described
nt amin
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and respiroviruses.
The nucleoprotein gene
The mRNA for the N gene of NV is predicted to be 2242
nt long, and two ORFs of substantial size were found.
The largest ORF is 1599 nt in length and is predicted to
encode a protein of 532 amino acids (calculated Mr of
57993), which is identical to the size of the N gene of HV
(Yu et al., 1998b) (Table 2). The larger ORF begins with
the first available AUG codon from the 59 end of the
mRNA. The sequences flanking the AUG codon are not in
a favorable translational initiation context (Kozak, 1991);
however, based on homology to HV and the lack of
another in-frame AUG codon within 207 nt, it is predicted
that this AUG codon is used for translation initiation of
the N protein. A second ORF begins 1483 nt downstream
from the start site of the N protein and potentially en-
codes a 72-amino-acid protein that is not found in HV
and has no significant homologies with any known pro-
tein. The initiating AUG for this potential ORF is not in a
favorable translational initiation context.
The homology between the coding sequences for the
N proteins of NV and HV is 78.4%; however, the level of
nucleotide homology within the 59 and 39 nontranslated
regions of the N gene mRNA of NV and HV decreases to
T
Comparison of the Sequences of the
Gene Virus
ORF
Lengtha
% Amino acid
identityb
% Nucle
homol
N Hendra 532 92.1 78.
Nipah 532
P Hendra 707 67.6 70.
Nipah 709
V Hendra 55 81.1 88.
Nipah 52
C Hendra 166 83.2 85.
Nipah 166
M Hendra 352 89.0 77.
Nipah 352
F Hendra 546 88.1 74.
Nipah 546
G Hendra 604 83.3 70.
Nipah 602
a Length in amino acids.
b Percent identity or homology after sequences were aligned using
c Length in nucleotides. HV gene lengths and 59 and 39 nontranslated
AF017149. Primers derived from the previously published genomic seq
and that sequence is used in comparison shown in the table. The perce
changes.66.7% and 41.1%, respectively (Table 2). Overall, the N
proteins of NV and HV are quite conserved (Table 2), butthe amino acid changes are not distributed evenly
across the protein (Fig. 2). The identity of the first 400
amino acids of the proteins is 98% between HV and NV,
with 6 of the 8 substitutions being conservative. How-
ever, 22 of the 42 amino acid differences between the N
proteins of NV and HV are located in a 28-amino-acid
region in the carboxyl-terminal portion of the protein, and
only 5 of these are conservative.
The P/V/C gene
The mRNA for the P/V/C gene is predicted to be 2704
nt long with an ORF of 2130 nt that is predicted to encode
P (Table 2). As observed for the N gene, the sequence
coding for the P of NV has higher levels of homology to
HV than the sequences of the 59 and 39 nontranslated
regions (Table 2). Translation of NV P is predicted to
begin at the first AUG available in the reading frame, and
the predicted P of NV is 2 amino acids longer than the P
protein of HV (Wang et al., 1998). Overall, the NV and HV
P proteins share 67.6% identity, whereas the amino-ter-
minal 137 amino acids and the carboxyl-terminal 321
amino acids have identities of approximately 80% (Fig.
3A). However, the region of the NV P protein between
amino acids 138–389 has only 43% identity to HV, and
only 17% of these substitutions are conservative.
Like the P gene of HV, the respiroviruses, and the
/V, M, F, and G Genes of HV and NV
59 Nontranslated 39 Nontranslated
Lengthc % Homologyb Lengthc % Homologyb
57 66.7 568 41.1
57 586
105 41.9 469 40.9
105 469
100 40.0 200 40.0
100 200
272 44.1 418 41.4
284 412
233 43.8 516 45.6
233 504
m GCG.
ces and gene lengths were obtained from GenBank accession number
were used to amplify and sequence the N, P, M, F, and G ORFs of HV
o acid identity does not take into consideration conserved amino acidABLE 2
N, P/C
otide
ogyb
4
5
5
0
1
2
8
GAP fro
sequen
uencemorbilliviruses (Bellini, 1998), a second ORF encoding
the C protein of NV begins with consecutive AUG codons
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338 HARCOURT ET AL.located 23 and 26 nt downstream of the P protein initia-
tion codon. It has not been established which AUG
codon is the actual initiator of translation. If translation is
initiated at the first AUG codon, the predicted C protein of
NV is 166 amino acids in length and has an Mr of 19735.
t is identical in size to the C protein of HV and has a
omology of 85.0% at the nucleotide level and an identity
f 83.2% at the amino acid level (Table 2). Except for the
egion between amino acids 31 and 45, which contains
1 nonconserved amino acid substitutions, the C pro-
eins of NV and HV differ at 17 amino acid positions, and
of these are conservative (Fig. 3B). HV contains another
RF in the same frame as C that putatively encodes a
hort basic protein (SB) of 65 amino acids (Wang et al.,
998), but this ORF is not found in the NV P gene.
Like most members of the subfamily Paramyxovirinae
Bellini, 1998), the P gene of NV contains a conserved
G-rich region (edit site) in which the viral polymerase
dds nontemplated Gs to the mRNA (Paterson and
amb, 1990). The identification of plasmid clones of NV P
ontaining 0, 1, or 2 G insertions at this site indicated that
NA editing occurs in NV. The RNA editing site of NV is
dentical to the editing site found in both HV and in some
f the morbilliviruses (Table 3). As in HV and the morbil-
FIG. 2. Comparison of the N proteins of NV and HV. The alignment sh
positions that differ in the N proteins of NV and HV. Conservative amino
in the NV N protein; dots mark lengths of 10 amino acids.iviruses, the unedited message is predicted to code for
. The addition of a single nontemplated G allows access
f
fo a cysteine-rich reading frame, producing a predicted V
rotein containing the amino-terminal part of P and 52
mino acids unique to the V reading frame. The pre-
icted V protein of NV is 3 amino acids shorter than the
in HV (Wang et al., 1998) and has an identity of 81.1%
ith the HV V (Table 2). All of the cysteine residues
xcept one are conserved between NV and HV (Fig. 3C).
he addition of two nontemplated G residues to the P
RNA allows access to a 47-amino-acid ORF and po-
entially encodes a protein that would be analogous to
he W protein that has been described for Sendai virus
Steward et al., 1993; Vidal et al., 1990). This potential
RF is also conserved in HV and is predicted to be of the
ame size as NV.
he matrix gene
The mRNA for the M gene is predicted to be 1359 nt
n length, with an ORF of 1059 nt encoding the pre-
icted M protein (Table 2). HV and NV have a homol-
gy of 77.1% in the ORF, but the 39 and 59 noncoding
egions have an homology of only 40% (Table 2). Based
n homology to HV, the first available AUG codon is
redicted to initiate translation, and this codon is in a
e predicted amino acid sequence of the N protein of NV and indicates
anges are shown in bold. Numbers correspond to amino acid positionsows thavorable context for translation. There is another in-
rame initiation codon 36 nt downstream from the first
339MOLECULAR CHARACTERIZATION OF NIPAH VIRUSFIG. 3. Comparison of the P, V, and C proteins of NV and HV. Alignments show the predicted amino acid sequence of the NV P (panel A), C (panel
B), and V (panel C) proteins and the amino acids that differ in the P, C, and V proteins of HV. Numbers correspond to amino acid positions in the NV
P, C, or V protein; dots mark lengths of 10 amino acids. Gaps (indicated by dashes) were made in the alignment of the P to maximize the regions of
homology. Conservative amino acid changes are shown in bold. Asterisk indicates the COOH terminus of the protein. During sequencing of the P
gene of HV, we found that an additional A nucleotide was inserted at position 1526 of the published P sequence and a T nucleotide was deleted at
position 1559 (Wang et al., 1998). These nucleotide changes result in 12 amino acid changes.
c
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amino acids that differ in the M protein of HV. Conservative amino acid chan
in the NV M protein; dots mark lengths of 10 amino acids.
sources described previously. PDV sequence was obtained from Gen-
Bank accession number D10371.
340 HARCOURT ET AL.AUG that could be used to initiate translation, but it is
in a less favorable context for translation. The M ORF
is predicted to encode a 352-amino-acid protein with
an M r of 39928. Of the 39 predicted amino acid
hanges between the M proteins of NV and HV, 12
ccur within the first 13 amino acids and 16 of these 39
ubstitutions are conservative (Fig. 4).
he fusion gene
The mRNA for the F gene is predicted to be 2337 nt in
ength, with an ORF of 1641 nt encoding the F protein
Table 2). HV and NV have an homology of 74.2% in the
RF, but the 39 and 59 noncoding regions have homolo-
gies of only 41.4% and 44.1%, respectively (Table 2). There
are two in-frame AUG codons available for initiation
within the first 22 amino acids; however, neither of them
is in an optimal context (Kozak, 1991). If the first AUG is
used to initiate translation, the ORF is predicted to en-
code a 546-amino-acid protein that is the same size as
the HV F (Gould, 1996) and the NV F protein would have
a predicted Mr of 60233.
Like the F proteins of other Paramyxoviridae (Lamb
and Kolakofsky, 1996), the NV F protein is predicted to be
a type I transmembrane protein with a membrane span-
ning domain located at amino acids 489–518 (Fig. 5) and
a short cytoplasmic region of approximately 30 amino
acids. The first 28 amino acids of the NV F protein have
only 6 amino acids in common with the same region of
the HV F (13 if conservative amino acid changes are
allowed). Despite these amino acid substitutions, this
region is hydrophobic in both viruses and is predicted toFIG. 4. Comparison of the M proteins of NV and HV. The predicted amino acid sequence of the NV M open reading frame is shown along with theTABLE 3
Comparison of the RNA Editing Sites of HV and NV with Other
Members of the Subfamily Paramyxovirinae
Virus Editing site Insertions Protein
HV GGGUAAUUUUUCCC GUGUC 11G V
NV GGGUAAUUUUUCCC GUGUC 11G V?
Genus Morbillivirus
MV GGGUAAUUUUUCCC GUGUC 11G V
PDV GGGUAAUUUUUCCC GUGUC 11G V
CDV AGGUAAUUUUUCCC GUGUC 11G V
Genus Respirovirus
HPIV-3 CUUAAUUUUUUCCC CCUUU 11G V
Sendai AGUUGUUUUUUCCC GUAUC 11G V
Genus Rubulavirus
NDV UUACGAUUUUUCCC GGGUA 11G V
HPIV-2 GUUGAAAUUCUCCC CCCCU 12G P
SV5 GCUAAAAUUCUCCC CGUCC 12G P
HPIV-4 CUAUAAAUUCUCCC CCCUU 12G P
Mumps UCUUAAAUUCUCCC CCCGG 12G P
Note. Genomic sequences (39 to 59) are shown. The nontemplated G
nucleotide or nucleotides are added to the mRNA either within or after
the run of genomic C residues. It has recently been demonstrated that
in Sendai virus, the G residue is added after the second C residue
(Hausmann et al., 1999). Also shown are the G insertions required to
produce the V protein for HV, NV, the morbilliviruses, and the respiro-
viruses and the P protein for the rubulaviruses. Abbreviations: New-
castle disease virus (NDV), phocine distemper virus (PDV), and Simian
virus 5 (SV5). The editing sites for MV, HPIV-3, Sendai, NDV, HPIV-2,
SV5, HPIV-4, and mumps were obtained from Collins et al. (1996). The
sequence of the editing sites for HV and CDV were obtained fromges are shown in bold. Numbers correspond to amino acid positions
tK
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initiate translation in NV, this signal sequence would not
be present in the protein.
Paramyxoviridae F proteins are synthesized as an in-
active precursor (F0) that is cleaved by host cell pro-
eases to release the new amino-terminus of F1, thus
forming the biologically active protein consisting of the
F1 peptide disulfide-linked to the F2 peptide (Lamb and
olakofsky, 1996). The predicted cleavage site for NV is
hown in Table 4. A lysine-to-arginine change is the only
ifference between HV and NV in the cleavage site
Table 4). The amino-terminal 20 amino acids of the F1
peptide of NV are hydrophobic and share extensive ho-
mology with the rubulaviruses, morbilliviruses, and re-
spiroviruses (Table 4). Interestingly, the amino-terminal
amino acid of the F1 peptide of both HV and NV is a
leucine, whereas in every other member of the
Paramyxoviridae, except for some avirulent strains of
NDV, it is a phenylalanine.
Apart from the amino-terminal 28 amino acids, the F
FIG. 5. Comparison of the F proteins of NV and HV. The alignment sh
ositions that differ in the F proteins of NV and HV. Conservative amino
n the NV F protein; dots mark lengths of 10 amino acids. Double underl
ndicate potential N-linked glycosylation sites. Longer single underlined
equence.proteins of HV and NV have only 19 nonconservative and
27 conservative amino acid changes throughout the restof the molecule. The 200 amino acids that comprise the
amino-terminal portion of the F1 proteins share more
than 96% homology. The F protein of NV is predicted to
have six, N-linked glycosylation sites, with three in the F1
peptide and three in the F2 peptide. These sites are also
conserved in HV, but HV also has one additional site in
the cytoplasmic domain.
The glycoprotein (G) gene and antigenic analysis
The gene coding for the putative attachment glyco-
protein of NV virus is 2543 nt in length and contains an
ORF encoding a protein of 602 amino acids (Mr 5 67038)
that has 83.3% identity to the G protein of HV. The pre-
dicted G protein of NV is two amino acids smaller than
the G protein of HV (Table 2). Only two of the three
in-frame initiation codons at the start of the reading
frame for the G protein of HV are conserved in the G
protein of NV (Yu et al., 1998a). Because the amino-
termini of these glycoproteins have not yet been se-
e predicted amino acid sequence of the F protein of NV and indicates
anges are shown in bold. Numbers correspond to amino acid positions
icates the position of the F1–F2 cleavage site. Single underlined triplets
at the COOH-terminus of the F protein indicates the membrane anchorows th
acid ch
ine indquenced, it is not known whether the predicted 50%
amino acid variation observed over the first 30 amino
a(access
342 HARCOURT ET AL.acids for these proteins is expressed (Fig. 6). Although
the lengths of the 59 nontranslated regions of the mRNA
re the same for NV and HV, the 39 untranslated region of
the HV mRNA is 12 nt longer (Table 2).
Overall, there are 128 predicted amino acid substi-
tutions between the G proteins of NV and HV. How-
ever, all 17 cysteines, all 8 N-linked glycosylation sites,
and 31 of 36 proline residues in NV are conserved. The
G proteins of HV and NV are predicted to be type II
membrane glycoproteins. There are only two amino
acid substitutions in the predicted hydrophobic trans-
membrane domains of the G proteins of HV and NV
and only one of these is nonconservative (Fig. 6). In
both G proteins, the first 100 amino acids of the extra-
cellular domain are relatively conserved with approx-
imately 90% homology, whereas the level of homology
for the remainder of the extracellular domain de-
creases to approximately 75%.
Neutralizing antibodies against the Paramyxoviridae
are directed against the surface glycoproteins. Although
the G and F proteins of HV and NV have over 80% amino
acid homology, neutralization tests using hyperimmune
mouse ascitic fluids to HV or NV detected significant
antigenic differences (Table 5) between these viruses.
There was an 8- to 16-fold difference in neutralization
titers between the homologous and heterologous ascitic
fluids.
Phylogenetic analyses
T
Comparison of the Fusion Protein Cleavage Sequ
Virus Cleavage peptidea
Hendra L-D-V-G-V-K
Nipah L-D-V-G-V-R
Respiroviruses
HPIV-1 D-N-P-Q-S-R
HPIV-3 D-P-R-T-K-R
Sendai G-V-P-Q-S-R
Morbilliviruses
Measles S-R-R-H-K-R
CDV S-R-R-K-K-R
Rinderpest S-R-R-H-K-R
Rubulaviruses
Mumps S-R-R-H-K-R
SV5 T-R-R-R-R-R
NDV G-R-R-Q-K-R
NDV (avirulent) G-G-R-Q-G-R
Pneumoviruses
RSV K-K-R-K-R-R
BRSV K-K-R-K-R-R
PVM K-R-K-K-R
a Sequences from Bellini et al. (1998) except for sequence for NDVPhylogenetic analyses of the nucleotide sequences of
the N, P, C, M, F, and G ORFs from representatives of thesubfamily Paramyxovirinae showed that HV and NV con-
sistently formed a unique cluster that was more closely
related to the morbilliviruses and the respiroviruses than
to the rubulaviruses (Fig. 7). Bootstrap confidence levels
of 100% for the N, P, C, F, and G sequences supported
these conclusions. The recently described Tupaia
paramyxovirus (Tidona et al., 1999) was also not included
within any of the known genera but was more closely
related to HV and NV than to any of the other viruses
(Figs. 7A–7C). These observations suggested that HV
and NV should be considered as a fourth new genus
within the Paramyxovirinae.
DISCUSSION
In this report, we describe the molecular characteriza-
tion of the N, P, M, F, and G genes of NV, a newly
described and highly pathogenic member of the
Paramyxoviridae. Sequence analysis indicated that NV is
more closely related to HV than to any other member of
the Paramyxoviridae. Although the viruses are close rel-
atives, they are clearly different viruses. The levels of
nucleotide sequence homology between the N, P, M, F,
and G ORFs of NV and HV are similar to the levels of
homology observed between related viruses within the
other genera of the subfamily Paramyxovirinae. These
two viruses form a group that is distinct from any of the
established genera and should be considered as a new
genus. Until the isolation of NV, HV had been the sole
member of this proposed new genus.
of HV and NV with Those of the Paramyxoviridae
NH2 terminus of F1
a
L-A-G-V-V-M-A-G-I-A-I-G-I-A-T-A-A-Q-I-T
L-A-G-V-I-M-A-G-V-A-I-G-I-A-T-A-A-Q-I-T
F-F-G-A-V-I-G-T-I-A-L-G-V-A-T-A-A-Q-I-T
F-F-G-G-V-I-G-T-I-A-L-G-V-A-T-S-A-Q-I-T
F-F-G-A-V-I-G-T-I-A-L-G-V-A-T-S-A-Q-I-T
F-A-G-V-V-L-A-G-A-A-L-G-V-A-T-A-A-Q-I-T
F-A-G-V-V-L-A-G-A-A-L-G-V-A-T-A-A-Q-I-T
F-A-G-V-A-L-A-G-A-A-L-G-V-A-T-A-A-Q-I-T
F-A-G-I-A-I-G-I-A-A-L-G-V-A-T-A-A-Q-V-T
F-A-G-V-V-I-G-L-A-A-L-G-V-A-T-A-A-Q-V-T
F-I-G-A-V-I-G-S-V-A-L-G-V-A-T-A-A-Q-I-T
L-I-G-A-I-I-G-G-V-A-L-G-V-A-T-A-A-Q-V-T
F-L-G-F-L-L-G-V-G-S-A-I-A-S-G-V-A-V-S-K
F-L-G-F-L-L-G-I-G-S-A-I-A-S-G-V-A-G-S-K
F-L-G-L-I-L-G-L-G-A-A-V-T-A-G-V-A-L-A-K
ion number AF048763) and avirulent NDV (Glickman et al., 1988).ABLE 4
encesIt is difficult to discern from the sequence data
whether HV and NV are more closely related to the
V
b
T
lining i
s the C
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343MOLECULAR CHARACTERIZATION OF NIPAH VIRUSrespiroviruses or to the morbilliviruses. In fact, HV and
NV contain genetic characteristics from both of these
genera. For example, the RNA editing sites of HV and NV
are identical to those of many morbilliviruses, whereas
the transcriptional termination signals are more closely
FIG. 6. Comparison of the G proteins of NV and HV. The alignment sh
positions that differ in the G proteins of NV and HV. Conservative amino
in the NV G protein; dots mark lengths of 10 amino acids. Double under
triplets indicate potential N-linked glycosylation sites. Asterisk indicate
TABLE 5
Cross-Neutralization of HV and NV
Neutralizationa titer versus
Antibody Hendra Nipah
Hendra-HMAFb 640 80
Nipah-HMAFb 20 320
a Determined by plaque neutralization as described in Materials and
ethods.
b f
t
Hyperimmune mouse ascites fluid was prepared as described in
Materials and Methods.related to those of the respiroviruses. The intergenic
sequences from HV and NV are identical to those in both
the morbilliviruses and respiroviruses, and the transcrip-
tion initiation signals of HV and NV are closely related to
both of these two genera. It is interesting to note that the
transcriptional initiation signals of HV, NV, the respirovi-
ruses, and the morbilliviruses are identical at positions 1,
2, 3, and 10, and each has a pyrimidine residue at
position 4.
Like the morbilliviruses, the respiroviruses, and HV, NV
is predicted to encode multiple proteins from the P gene
(Bellini, 1998; Griffin and Bellini, 1996; Patterson, et al.,
1989; Thomas et al., 1988; Wang et al., 1998). The C and
proteins are predicted to be made by NV and have
een identified in HV-infected cells (Wang et al., 1998).
he cysteine-rich region of the V protein forms a zinc
e predicted amino acid sequence of the G protein of NV and indicates
anges are shown in bold. Numbers correspond to amino acid positions
ndicates the position the membrane anchor domain. Single underlined
OOH-terminus of the protein.ows th
acid chinger domain, and the V protein of MV has been shown
o bind zinc (Liston and Briedis, 1994). The NV V would
r
c
r
H
a
f
e
b
i
N
o
v
r
d
b
1
i
c
H
w
H
a
q
P
t
P
a
b
T
p
r
n
s
q
m
s
s
t
b
r
o
i
i
M
S
344 HARCOURT ET AL.be predicted to have a similar domain because all of the
cysteine residues that are conserved in the V proteins of
the morbilliviruses and the respiroviruses are conserved
in NV (Baron et al., 1993). In addition, only one cysteine
esidue is not conserved between NV and HV, and this
ysteine is not found in any of the other paramyxovi-
uses. Insertion of 2 Gs at the editing site of both NV and
V is predicted to produce a protein that would be
nalogous to the W proteins that have been described
or other Paramyxovirinae (Delenda et al., 1998; Steward
t al., 1993; Vidal, et al., 1990).
The fusion cleavage site of the morbilliviruses, rubu-
laviruses, and pneumoviruses are highly basic and con-
tain the R-X-R/K-R consensus sequence that is required
for cleavage by furin (Hosaka, 1991). However, neither
HV nor NV contains this sequence in their respective
cleavage sites, so these viruses must use other host cell
proteases. The respiroviruses also do not have furin
cleavage sites and must have exogenous proteases
added to grow in tissue culture (Scheid and Choppin,
1974). Unlike Sendai, neither HV nor NV requires the
addition of exogenous proteases for growth in tissue
culture, so the proteases responsible for HV and NV F0
cleavage must differ from those used by the respirovi-
ruses. In addition, the lysine-to-arginine change at posi-
tion six of the cleavage site in NV may affect the range of
proteases able to cleave the protein and/or the efficiency
of cleavage.
The amino-terminal 20 amino acids of the F1 peptide
are highly conserved between HV and NV and the other
Paramyxovirinae. This region is thought to initiate the
fusion process by intercalating into membranes of host
cells (Lamb and Kolakofsky, 1996). Except for some avir-
ulent strains of NDV, HV and NV are unique within the
Paramyxoviridae in having a leucine at the amino-termi-
nus of the F1 peptide rather than a phenylalanine. The
iological consequences of this amino acid substitution
n HV and NV are unknown. For the avirulent strain of
DV, amino acid substitutions that destroy the furin rec-
FIG. 7. Phylogenetic analyses of the N, P, C, M, F, and G ORFs from m
4.02 was performed on viral sequences from the following genes: N (pa
trees shown were based on maximum parsimony; however, analysis o
topologies (data not shown). DMV, dolphin morbillivirus; PDPR, peste-
number of nucleotide changes is shown for each phenogram. access
HPIV-2, M55320; HPIV-3, D10025; Mapuera, X85128; Mumps, D86172; M
X00087; SV5, M81442; and Tupaia, AF079780; (panel B) CDV, X51869;
M55976; Mumps, D86173; MV, M89920; NDV, M20302; PDV, X75960; RP
CDV, AF014953; DMV, Z47758; HPIV-1, M74081; HPIV-3, D00047; MV, AB0
M12669; DMV, Z30087; HPIV-1, S38067; HPIV-2, M62734; HPIV-3, D001
AF089819; PDPR, Z47977; PDV, X75717; RPV, M34018; Sendai, U31956;
HPIV-2, M60182; HPIV-3, X05303, HPIV-4a, D49821; HPIV-4b, D49822; M
RPV, M21514; Sendai, D17334; SV5AB021962; (panel F) CDV, AF112189; D34033; HPIV-4B, AB006954; Mumps, X99040; MV, K01711; NDV, AF204872;
76876.gnition sequence may also contribute to the loss of
irulence.
The F proteins of the Paramyxoviridae contain heptad
epeat regions immediately after the 20-amino-acid hy-
rophobic fusion region and adjacent to the transmem-
rane region (Buchholz et al., 1993; Chambers et al.,
990). The heptad repeats are composed of leucine/
soleucine zipper domains that can form a triple-stranded
oil composed of three a-helices (O’Shea et al., 1989;
arbury et al., 1994). In the regions of the F protein that
ould be expected to contain the heptad repeats, both
V and NV share a high level of amino acid homology. In
ddition, all cysteine residues outside of the signal se-
uence are conserved between HV and NV and the other
aramyxovirinae, suggesting that the HV and NV F pro-
eins are structurally similar to the F proteins of other
aramyxovirinae.
HV is unique among the Paramyxovirinae in having an
ttachment glycoprotein lacking detectable erythrocyte
inding and neuraminidase activities (Yu et al., 1998a).
he sequence of the G protein of HV was recently com-
ared with the structural alignment of the globular head
egions of the attachment proteins of the Paramyxoviri-
ae (Langedijk et al., 1997; Yu et al., 1998a). Whereas the
equence of the HV G protein had only minimal se-
uence homology with the attachment proteins of other
embers of the Paramyxovirinae, several important
tructural features were conserved. The locations of all
even of the proposed disulfide bonds between HV and
he respiroviruses are conserved, and five of these
onds are also shared between HV and the rubulavi-
uses and the morbilliviruses. There also is conservation
f structurally important amino acids, but the amino ac-
ds residues that are necessary for neuraminidase activ-
ty are not conserved in HV (Yu et al., 1998a). Most of
these important amino acid residues are conserved in
the G proteins of both HV and NV, including the eight
residues that are highly conserved among the attach-
s of the Paramyxovirinae subfamily. Phylogenetic analysis using PAUP
P (panel B), C (panel C), M (panel D), F (panel E), and G (panel F). The
me data using maximum likelihood gave TREES with nearly identical
tits-ruminants virus; and RPV, rinderpest virus. Scale representing the
bers used: (panel A) CDV, AF014953; DMV, X75961; HPIV-1, D01070;
11; NDV, AF064091; PDPR, X74443; PDV, X75717; RPV, X68311; Sendai,
Z47758; HPIV-1, M74081; HPIV-3, X04721; HPIV-4a, M55975; HPIV-4b,
11; Sendai, M30202; SV5, AF052755; and Tupaia, AF079780; (panel C)
RPV, X68311; Sendai, AB005796; and Tupaia, AF079780; (panel D) CDV,
V-4a, D10241; HPIV-4b, D10242; Mumps, D86171; MV, AB012948; NDV,
5, M32248; (panel E) CDV, M21849; DMV, AJ224704; HPIV-1, M22347;
D86169; MV, AB003178, NDV, AF048763; PDPR, Z37017; PDV, AJ224706;
224705; HPIV-1, U709498; HPIV-2, D000865; HPIV-3, AB012132; HPIV-4A,ember
nel A),
f the sa
des-pe
ion num
V, K017
DMV,
V, X683
16162;
30; HPI
and SV
umps,
MV, AJPDPR, Z81358; PDV, Z36979; RPV, AF132934; Sendai, U06433; SV-5,
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346 HARCOURT ET AL.ment proteins of viruses in the subfamily Paramyxoviri-
nae (Yu et al., 1998a).
Despite the conservation of important structural fea-
tures of the G and F proteins of HV and NV, amino acid
substitutions in the extracellular domains of these pro-
teins lead to significant antigenic differences in neutral-
ization assays. HV and NV do not react with antiserum to
any of the other paramyxoviruses (Chua et al., 1999,
2000) but do share cross-reactive epitopes with each
other. Enzyme immunoassays that were developed to
support the investigation of the outbreak of NV in Malay-
sia initially used HV as the source of antigen (Anony-
mous, 1999a).
As described above, HV and NV share characteristics
with other members of the Paramyxovirinae, such as
gene order, conserved intergenic, transcriptional initia-
tion, and transcriptional termination sequences, a con-
served mRNA editing site, the presence of the C and V
ORFs in the P gene, and the overall structure of the
surface glycoproteins required for attachment and mem-
brane fusion. The amino acid heterogeneity in the car-
boxyl-terminal portion of the N protein and the central
region of the P protein along with the relative conserva-
tion of the M protein have been described for other
members of the Paramyxovirinae (Baczko et al., 1992;
Taylor et al., 1991). However, HV and NV have several
characteristics that clearly separate them from the es-
tablished genera. Members of the Paramyxoviridae typ-
ically have genomes that are approximately 15,500 nt in
length (Bellini et al., 1998), whereas the HV genome is
composed of 18,234 nt (GenBank accession number
AF017149). Presumably, the NV genome will be of a
similar length based on the degree of homology ob-
served for the first five genes of these two viruses. With
the exception of the M gene, the genes of HV and NV
have 39 nontranslated regions that are much longer than
those found in any other member of the subfamily
Paramyxovirinae and would partially explain the longer
length of the HV and NV genomes. In the order Mono-
negavirales, the only other viruses that contain such
large 39 nontranslated regions are the filoviruses (Feld-
mann et al., 1992; Sanchez et al., 1993). It is interesting to
note that although the sizes of the 39 nontranslated
regions are conserved between NV and HV, the level of
sequence homology is quite low. It is possible that de-
spite the sequence differences, RNA secondary struc-
tures are conserved that could be important in mRNA
stability and/or “translatability.” In addition, both HV and
NV have P proteins that are more than 100 amino acids
larger than any other P protein found in other members
of the family. Finally, the attachment protein of HV, and
presumably that of NV, is unique among the Paramyxo-
virinae in having no detectable neuraminidase or eryth-
rocyte binding activities.
In addition to the unique features of the genomes of
5
(HV and NV described above, both HV and NV are unique
among the Paramyxovirinae in that they have unusually
broad host ranges. HV has been shown to infect horses,
humans, cats, rabbits, fruit bats (Wang et al., 1998; West-
ury, 1995), and a wide array of cell lines (Murray, 1995).
V is pathogenic in humans, horses, cats, and guinea
igs (Hooper, 1997; Westbury et al., 1996). During the NV
outbreak in Malaysia, humans, pigs, cats, and dogs were
infected and had disease. NV N gene sequences ob-
tained from tissue samples from humans, pigs, cats, and
dogs were identical to each other and to the sequence
obtained from viral isolates (Anonymous, 1999b; and un-
published observations). In addition, HV and NV contain
cross-reactive antigenic domains that are not shared
with any other members of the Paramyxovirinae.
In summary, the phylogenetic analysis of the N, P, C,
M, F, and G ORFs of HV and NV illustrate that these
viruses do not group within any of the established gen-
era of the subfamily Paramyxovirinae. Furthermore, the
unique features of the HV and NV genomes, their broad
host range, and antigenic cross-reactivity clearly indicate
that NV and HV should be considered members of a new
genus within the subfamily Paramyxovirinae.
MATERIALS AND METHODS
Virus culture and RNA isolation
The NV strain used in this study was isolated directly
from brain tissue in Vero E6 cells. The virus was pas-
saged one time in Vero E6 cells and harvested when the
cytopathic effect was maximal. All work with live virus
was performed under BSL-4 conditions. RNA was ex-
tracted from the infected cells by using the guanidinium
acid–phenol technique (Chomczynski and Sacchi, 1987).
Amplification of viral sequences
RT–PCR was performed as previously described (Rota
et al., 1994) except that the cycling conditions were 95°C
for 3 min, followed by 35 cycles of 95°C for 1 min, 50°C
for 2 min, and 72°C for 3 min. The reaction was then
incubated at 72°C for an additional 5 min. PCR products
were visualized using agarose gel electrophoresis and
were purified by using the Wizard PCR Preps DNA Puri-
fication System (Promega, Madison, WI). Figure 1 shows
the RT–PCR products used to construct the nucleotide
sequence of the NV N, P, M, F, and G genes. The follow-
ing primers were used for the indicated RT–PCR prod-
ucts (restriction enzyme sites are underlined): (A) 141 bp,
59-CATTAAAAAGGGCACAGACGC-39 and 59-TGGACAT-
TCTCCGCAGT-39; (B) 726 bp, 59-CATTAAAAAGGGCACA-
ACGC-39 and 59-TCTGCCAAAGGAACAAATTGTGATG-
9; (C) 827 bp, 59-TCCTGAGCTTAAACCAGTGAT-39 and
9-CCGGTACC(T35)-39 [oligo(dT)]; (D) see 59 RACE below;
E) 552 bp; 59-ATCAATCGTGGTTATCTTGAA-39 and 59-
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347MOLECULAR CHARACTERIZATION OF NIPAH VIRUSGATATCTAGATCACACGTCTGCTCTAAC-39 (XbaI); (F)
1005 bp, 59-GCTGCAGTTCAGGAAACATCAG-39 and oli-
go(dT); (G) 1201 bp, 59-ACCGAACAAGGGGAAATATGG-39
this primer represents the 39 end of the HV genome) and
9-GGCCTAGTCTGAAATACATAG-39; (H) 319 bp, 59-ACT-
TCACAAAGATCAATGATTC-39 and 59-CACCATTGATCT-
AATGTGGAG-39; (I) 730 bp, 59-ACTATCACAAAGAT-
AATGATTC-39 and oligo(dT); (J) 1356 bp, 59-AGGTAAT-
CTCGCACAAGTGA-39 and 59-TGCACAGACAGTTGAC-
ATCT-39; (K) 1295 bp, 59-TCAGACGATAACACAATA-
TT-39 and 59-CACCATTGATCTTAATGTGGAG-39; (L)
094 bp, 59- ACTATCACAAAGATCAATGATTC-39 and 59-
AACACTACACTCCGAGATCA-39; (M) 59-CTCTACTACAT-
GGGACATAG-39 and 59-TAGTAATGATCTAGATCTCCA-
9; (N) 1370 bp 59-ATGATGACCCGTCTAGCTGTG-39 and
ligo(dT); (O) 1599 bp, 59-GATCGTCGACATGAGT-
GATATCTTTGAAGAG-39 (SalI) and 59-GATATCT AGATCA-
CACATCAGCTCTGACGAA-39 (XbaI) (ORF for N); (P), 2130
bp, 59-ATGGATAAATTGGAACTAGTC-39 and 59-TCAA-
ATATTACCGTCAATGAT (ORF for P); (Q) 1059 bp, 59-ATG-
AGCCGGACATCAAGAGT-39 and 59-TTAGAAGAATTCT-
TTTAGCC-39 (ORF for M); (R) 1641 bp, 59-GATCGAAT-
TCGACATGGTAGTTATACTTGAC-39 (EcoRI) and 59-GATC-
GGATCCGAATACACTATGTCCCAATGTAG-39 (BamHI) (ORF
for F); and (S) 1809 bp, 59-GATCGGATCCATGCCGGCA-
GAAAACAAGAA-39 (BamHI) and 59-GATCCTCGAGTA-
GATCAATCCATTAAATTATGAG-39 (XhoI).
The oligonucleotide primers used to synthesize cDNA
and amplify the ORFs of the Hendra N, P, M, F, and G
genes are as follows: N, 59-GATCGAATTCATGAGT-
GATATATTTGAC-39 (EcoRI) and 59-GATATCTAGATCA-
CACGTCTGCTCTAAC-39 (XbaI); P, 59-GATCGAGCTCATG-
GACAAGTTGGATCTAGTC-39 (SacI) and 59-GATCCTC-
GAGTTAGATGTTCCCATCAATAAT-39 (XhoI); M, 59-GATC-
GAGCTCACCTGA GTGGCCAGAACC-39 (SacI) and 59-
GATCCTCGAGAGTGAATGTTTTATTTCA-39 (XhoI); F, 59-
GATCCCATGGATTATTTATCTTTAAGCA-39 (NcoI) and 59-
GATCCTGCAGTGATTGTAGTGTATTTTA-39 (PstI); and G,
59-GATCGAATTCATGATGGCTGATTCC-39 (EcoRI) and 59-
GATACTCGAGTCAACTCTCTGAACA-39 (XhoI).
59 RACE and cloning
The protocol for 59 RACE was carried out according to
he recommendations of the manufacturer (Life Technol-
gies, Gaithersburg, MD). First-strand synthesis of cDNA
as primed using a NV P gene-specific primer (NVPER:
9-ACACTCTTGCCTTCTTGGTAG-39) and 1 mg of infected
ell RNA. PCR amplification of the tailed first-strand
DNAs was done by using the primer NVPER and the
bridged Anchor primer. PCR products were purifiedsee above) and cloned into a plasmid vector, pCR2.1
InVitrogen, San Diego, CA).onstruction of cDNA library for NV
A cDNA library of NV-infected cells was prepared by
sing a commercial library construction kit (Life Technol-
gies, Gaithersburg, MD) according to the manufactur-
r’s protocols. Briefly, 3 mg of infected cell RNA was used
as template for first-strand synthesis of cDNA using a
NotI primer–adapter that binds to the poly(A) tail of
mRNA and Superscript II (Life Technologies) reverse
transcriptase. After second-strand synthesis by DNA
polymerase I, SalI adapters were added using T4 DNA
ligase. cDNA was then digested with NotI and size-
fractionated by column chromatography before being
ligated to NotI–SalI cut pSPORT I.
To screen for plasmid clones that containing NV F and
G gene inserts, colonies were transferred onto nylon
membranes and hybridized to digoxygenin-labeled
probes (Boehringer-Mannheim, Indianapolis IN) pre-
pared from plasmid clones of the G and F genes of HV
(unpublished data). Plasmid DNA from colonies that hy-
bridized to the HV F and G gene probes was further
analyzed by Southern blotting and DNA sequencing.
Sequence analysis
Plasmid DNA or purified PCR products were se-
quenced using a cycle sequencing reaction with fluores-
cent dye terminators (Perkin–Elmer, Applied Biosystems
Division, Foster City, CA), and the reaction products were
analyzed by using an ABI 373 automatic sequencer (Per-
kin–Elmer, Applied Biosystems Division). Sequencing
primers were provided with the plasmid cloning vectors
or were based either on the previously published se-
quence of HV (GenBank accession number AF017149) or
on the sequence of NV. Sequence data were analyzed
using version 10.0 of the Genetics Computer Group
package (Devereaux, 1984), PHYLIP version 3.4 (Felen-
stein, 1988), and PAUP (Swofford and Olsen, 1990). For
the analysis of conservative amino acid changes, amino
acids were grouped into families as follows: (F, Y), (M, L,
I, V), (A, G), (T, S), (E, D), (K, R), and any changes involving
an H, a P, a W, or a C were not considered conservative.
Neutralization tests
Mouse hyperimmune ascitic fluids (HMAF) for HV and
NV were prepared as previously described (Brandt et al.,
1967). Plaque reduction neutralization assays were per-
formed in the BSL-4 laboratory. Dilutions of HMAF to NV
or HV were incubated with approximately 100 pfu of HV
or NV before being transferred to Vero E6 cell monolay-
ers. Plaques were visualized after 6 days, and the neu-
tralizing antibody titer was recorded as the reciprocal of
the highest dilution of HMAF producing at least a 90%
reduction in plaque formation.
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